Shree Ganesh Remedies

Pharmaceuticals & Drugs
₹678.65
-0.38%
Prev close ₹681.25
Get AI-Powered Analysis for Shree Ganesh Remedies Free Analysis → FREE View live price, charts & full analysis for Shree Ganesh Remedies →

Shree Ganesh Remedies Share Price Chart

Shree Ganesh Remedies last traded at ₹678.65 (2026-10-13). Over the past month the stock moved +7.0%, three months the stock moved +4.5%, year the stock moved +23.7%. Its closing range over 52 weeks is ₹423.05 – ₹725.50, with the latest close 6.5% below the high.

Closing prices up to 2026-10-13.

About Shree Ganesh Remedies

Incorporated in 1995, Shree Ganesh Remedies Ltd is a manufacturer of Pharmaceutical Drug Intermediates for API & Fine Chemicals[1]

Business Overview:[1] SGRL is an ISO 14001 certified complex chemical manufacturer, specialising in pharmaceutical intermediates and speciality chemicals.

Fundamentals

Market Cap₹866.54 Cr
52W High₹759
52W Low₹381.10
P/E Ratio56.16
P/B Ratio5.29
EPS₹12.02
Dividend Yield0%
ROE (3yr)17%
Sales Growth (3yr)6%
Profit Growth (3yr)5%

Quarterly Results

In the latest quarter (Jun 2026), Shree Ganesh Remedies reported sales of ₹14.36 crore (-41.8%) and net profit of ₹1.12 crore (-67.5%), compared with the same quarter last year.

Shree Ganesh Remedies quarterly results (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Jun 202614.363.3523.331.120.87
Mar 202633.2011.3834.286.274.88
Dec 202521.116.7331.883.102.41
Sep 202530.329.6231.734.963.86
Jun 202524.677.3029.593.452.69
Mar 202524.439.8840.446.605.14
Dec 202427.059.9136.645.434.23
Sep 202432.3311.3134.986.425.00
Year-on-year change vs the same quarter last year
Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales growth-3.3%-3.3%-34.6%-0.4%-6.2%-22.0%+35.9%-41.8%
Operating profit growth+22.5%+20.7%-41.7%-10.2%-14.9%-32.1%+15.2%-54.1%
Net profit growth-2.0%+13.1%-47.6%-25.8%-22.7%-42.9%-5.0%-67.5%
EPS growth-2.3%+12.8%-47.8%-25.7%-22.8%-43.0%-5.1%-67.7%
OPM %35.0%36.6%40.4%29.6%31.7%31.9%34.3%23.3%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Annual Financials

In the latest year (Mar 2026), Shree Ganesh Remedies reported sales of ₹109.00 crore (+0.0%) and net profit of ₹18.00 crore (-21.7%), compared with the previous year.

Shree Ganesh Remedies annual profit & loss (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Mar 2026109.0035.0032.0018.0013.84
Mar 2025109.0039.0036.0023.0018.00
Mar 2024126.0042.0033.0028.0021.97
Mar 202391.0023.0026.0015.0011.86
Mar 202271.0018.0025.0013.0010.47
Mar 202149.0014.0028.0010.007.62
Mar 202058.0011.0019.0010.007.52
Mar 201935.009.0025.006.004.88
Year-on-year change vs the previous year
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales growth+29.6%+65.7%-15.5%+44.9%+28.2%+38.5%-13.5%+0.0%
Operating profit growth+80.0%+22.2%+27.3%+28.6%+27.8%+82.6%-7.1%-10.3%
Net profit growth+20.0%+66.7%+0.0%+30.0%+15.4%+86.7%-17.9%-21.7%
EPS growth+33.3%+54.1%+1.3%+37.4%+13.3%+85.2%-18.1%-23.1%
OPM %25.0%19.0%28.0%25.0%26.0%33.0%36.0%32.0%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Shareholding

Promoter Holding72.84%

AI Analysis

No AI analysis generated yet for Shree Ganesh Remedies.

Get Free AI Stock Analysis FREE →

Latest News

Frequently Asked Questions

What is Shree Ganesh Remedies's current stock price?

Shree Ganesh Remedies shares were last quoted at ₹678.65 (-0.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.

What is the P/E ratio of Shree Ganesh Remedies?

Shree Ganesh Remedies has a price-to-earnings (P/E) ratio of 56.16 and a price-to-book (P/B) ratio of 5.29. The industry P/E is 53.33.

What is the 52-week high and low of Shree Ganesh Remedies?

The 52-week high of Shree Ganesh Remedies is ₹759.00 and the 52-week low is ₹381.10.

What is the market cap of Shree Ganesh Remedies?

The market capitalisation of Shree Ganesh Remedies is about ₹866.54 crore.

How did Shree Ganesh Remedies perform in its latest quarterly results?

In the latest quarter (Jun 2026), Shree Ganesh Remedies reported sales of ₹14.36 crore (-41.8%) and net profit of ₹1.12 crore (-67.5%), compared with the same quarter last year.

Is Shree Ganesh Remedies a good stock to buy?

This page is for information and is not investment advice. As per the data shown here, Shree Ganesh Remedies has a 3-year ROE of 17.00%, 3-year profit growth of 5.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.

What is the promoter holding in Shree Ganesh Remedies?

Promoters hold about 72.84% of Shree Ganesh Remedies.

Which sector does Shree Ganesh Remedies belong to?

Shree Ganesh Remedies belongs to the Pharmaceuticals & Drugs sector.

Other Pharmaceuticals & Drugs stocks

All Pharmaceuticals & Drugs stocks · Browse all stocks A–Z

Go to live page for Shree Ganesh Remedies →